Loading…
Tiziana Life Sciences Ltd is projected to rise to $1.29 by 2027, a +5% move from its current price of $1.23. TLSA is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 12 | $1.18 | $1.23 | $1.28 | +0.03% |
| Jul 13 | $1.16 | $1.23 | $1.30 | +0.05% |
| Jul 14 | $1.15 | $1.23 | $1.32 | +0.08% |
| Jul 15 | $1.14 | $1.23 | $1.34 | +0.10% |
| Jul 16 | $1.12 | $1.23 | $1.35 | +0.13% |
| Jul 17 | $1.12 | $1.23 | $1.36 | +0.16% |
| Jul 18 | $1.11 | $1.23 | $1.37 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.11 | $1.23 | $1.37 | +0.18% |
| Week 2 | $1.06 | $1.23 | $1.44 | +0.37% |
| Week 3 | $1.03 | $1.24 | $1.49 | +0.55% |
| Week 4 | $0.9995 | $1.24 | $1.54 | +0.74% |
| Week 5 | $0.9763 | $1.24 | $1.58 | +0.92% |
| Week 6 | $0.9559 | $1.24 | $1.62 | +1.11% |
| Week 7 | $0.9377 | $1.25 | $1.66 | +1.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Tiziana Life Sciences Ltd is a healthcare company focused on the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally.
It develops Foralumab TZLS-401, a human anti-CD3 monoclonal antibody, which is Phase II clinical trial for the treatment of non-active secondary progressive multiple sclerosis, Alzheimer's disease, multi system atrophy, and amyotrophic lateral sclerosis; and TZLS-501, a human anti-IL-6R monoclonal antibody for the treatment of autoimmune and inflammatory diseases.
The company is headquartered in London, the United Kingdom.
TLSA is a healthcare stock currently trading at $1.26, with a market cap of $160.35M and a rank of 3977.
The price is trading near the 50-day simple moving average of $1.31 and below the 200-day simple moving average of $1.52, which places it in a modestly corrective near-term context.
The current technical picture is NEUTRAL, with RSI14 at 50 and a 30-day range of $0.9419 to $1.69. Support sits at $1.08 and resistance at $1.51, indicating a defined near-term trading band.
Forecasts over the multi-year horizon show movement from 2026 onward, with the 2026 avg at $1.26 and climbing toward higher averages such as $1.85 by 2030, extending to $4.46 by 2040 and $7.65 by 2050, with corresponding max prices and ROIs.
A major floor 28.7% below — a decisive break under it would weaken the trend.
The nearest floor, 12.2% below — buyers have tended to step in here.
The nearest ceiling, 18.7% above — a clean break opens room to run.
A major ceiling 33.1% above — clearing it would confirm fresh momentum.
Key TLSA support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TLSA market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $1.23 | Sell | $1.24 | Sell |
| MA 10 | $1.24 | Sell | $1.23 | Sell |
| MA 20 | $1.18 | Buy | $1.23 | Buy |
| MA 50 | $1.31 | Sell | $1.27 | Sell |
| MA 100 | $1.31 | Sell | $1.33 | Sell |
| MA 200 | $1.51 | Sell | $1.40 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 49.54 | Neutral |
| Stoch RSI (14) | 60.54 | Neutral |
| CCI (20) | 53.87 | Neutral |
| Williams %R (14) | -42.11 | Info |
| MACD (12,26,9) | 0.02 | Buy |
| ROC (12) | 6.03 | Buy |
| Bollinger %B (20,2) | 0.68 | Neutral |
| Stochastic %K (14) | 57.89 | Neutral |
| TRIX (15) | -0.32 | Sell |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 47.07 | Neutral |
| Momentum (10) | 0.10 | Buy |
| Aroon Osc (25) | 40.00 | Buy |
| Hull MA (9) | 1.25 | Sell |
| ADX (14) | 12.20 | Neutral |
| ATR (14) | 0.05 | Info |
The near-term technical picture is NEUTRAL, with RSI14 at 50 and the stock trading around its 50-day and 200-day moving averages (SMA50 = $1.31, SMA200 = $1.52).
The 30-day range spans from $0.9419 to $1.69, illustrating a defined short-term trading band. The stock shows a support level at $1.08 and a resistance level at $1.51, framing possible bounce or pullback points in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.08 | $1.23 | $1.63 | 0% | Neutral | |
| $0.9816 | $1.29 | $1.82 | +5% | Neutral | |
| $1.01 | $1.39 | $2.07 | +13% | Neutral | |
| $0.9914 | $1.41 | $2.19 | +15% | Neutral | |
| $1.17 | $1.73 | $2.76 | +40% | Bullish | |
| $1.45 | $2.20 | $3.62 | +79% | Bullish | |
| $1.52 | $2.38 | $4.02 | +94% | Bullish | |
| $1.57 | $2.53 | $4.36 | +105% | Bullish | |
| $1.43 | $2.36 | $4.17 | +92% | Bullish | |
| $1.43 | $2.41 | $4.34 | +96% | Bullish | |
| $2.10 | $4.00 | $7.79 | +225% | Bullish | |
| $3.03 | $6.73 | $14.70 | +447% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $1.08 | $1.23 | $1.46 | +0.00% |
| August 2026 | $1.02 | $1.21 | $1.50 | -1.26% |
| September 2026 | $1.04 | $1.26 | $1.58 | +3.73% |
| October 2026 | $1.01 | $1.24 | $1.57 | -1.96% |
| November 2026 | $0.9758 | $1.20 | $1.55 | -2.87% |
| December 2026 | $1.01 | $1.25 | $1.63 | +4.35% |
Click any year to see its month-by-month TLSA forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect TLSA to range from $1.08 to $1.63 through 2026. The $1.23 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The TLSA price prediction for 2027 points to an average of $1.29 (low $0.9816, high $1.82) — a potential gain of +5% on today's $1.23. Price action looks broadly range-bound.
In 2028, TLSA is projected to trade between $1.01 and $2.07, averaging $1.39 — a potential gain of +13% from today's $1.23. That is up +8% on the projected 2027 average. A consolidation phase looks the most probable path here.
Tiziana Life Sciences Ltd's 2029 outlook centres on $1.41, within a $0.9914 to $2.19 range. That is up +2% on the projected 2028 average. That marks a +15% change versus current levels. Price action looks broadly range-bound.
By 2030, TLSA could reach as high as $2.76, with a base case around $1.73 and support toward $1.17 — roughly +40% from $1.23. Buyers look set to stay in control over this stretch.
Expect TLSA to range from $1.45 to $3.62 through 2031. The $2.20 average target implies a +79% move from current prices. That is up +28% on the projected 2030 average. Momentum favours further upside here.
The TLSA price prediction for 2032 points to an average of $2.38 (low $1.52, high $4.02) — a potential gain of +94% on today's $1.23. Buyers look set to stay in control over this stretch.
In 2033, TLSA is projected to trade between $1.57 and $4.36, averaging $2.53 — a potential gain of +105% from today's $1.23. That is up +6% on the projected 2032 average. Momentum favours further upside here.
Tiziana Life Sciences Ltd's 2034 outlook centres on $2.36, within a $1.43 to $4.17 range. That is -6% versus the projected 2033 average. That marks a +92% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, TLSA could reach as high as $4.34, with a base case around $2.41 and support toward $1.43 — roughly +96% from $1.23. Momentum favours further upside here.
Expect TLSA to range from $2.10 to $7.79 through 2040. The $4.00 average target implies a +225% move from current prices. That is up +66% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The TLSA price prediction for 2050 points to an average of $6.73 (low $3.03, high $14.70) — a potential gain of +447% on today's $1.23. Momentum favours further upside here.
Investing $1,000 in TLSA today (≈ 813.00813 TLSA) could be worth
$5,472.3
+$4,472.3 (+447%) by 2050 · US Dollar
Based on the average projected TLSA price of $6.73 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TLSAwould be worth at today's price.
$1,000 invested in TLSA on Jul 10, 2025 (≈ 680.272096 TLSA) would be worth
$836.73
-$163.27 (-16.3%) today · 0.84× · US Dollar
Based on a TLSA entry price of $1.47 vs. today's $1.23.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $1.31 | $938.93 | -6.1% |
| 1 month ago | $1.16 | $1,060.34 | +6.0% |
| 3 months ago | $1.18 | $1,042.37 | +4.2% |
| 6 months ago | $1.37 | $897.81 | -10.2% |
| 1 year ago | $1.47 | $836.73 | -16.3% |
| All time (5.0y) ago | $2.17 | $566.82 | -43.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TLSA forecast.
Our base-case forecast reaches $2.50 around 2033.
Implied market cap at $2.50: $318.15M
The multi-year forecast points to a bullish trajectory beginning in the 2030s and extending through 2050. In 2030, the average price is projected to be $1.85 with a min of $1.23 and a max of $3.03, yielding a 47.1% ROI and a bullish sentiment.
By 2040, the forecast shows an average of $4.46 with a max of $8.99, delivering a 253.8% ROI and continuing bullish sentiment. By 2050, the average is projected at $7.65 with a max of $17.40, equating to a 507.5% ROI and sustained bullishness.
These are estimates, not guarantees, and reflect the projected path of TLSA prices alongside notable volatility (annualized volatilityPct = 80). The outlook suggests higher potential upside in the long run but acknowledges near- to mid-term uncertainty.
Tap a question to reveal the answer.
In 2030 the min is $1.23, the average is $1.85, and the max is $3.03, with a 47.1% ROI and a bullish sentiment.
The forecast shows a bullish path from 2030 onward with higher max prices and ROIs, but near-term remains NEUTRAL. These are estimates, not guarantees.
The forecast maximums reach $3.03 in 2030, $4.06 in 2031, $4.52 in 2032, $4.86 in 2033, and $4.87 in 2035, with $8.99 by 2040 and $17.40 by 2050. A $5 level is within the projected maxima in later years, but this remains an estimate, not a guarantee.
For 2026, the min is $1.08, the average is $1.26, and the max is $1.70, with 0% ROI and NEUTRAL sentiment.
Current price is $1.26 and market cap is $160.35M.
Tiziana Life Sciences Ltd Community Discussion
0Share your Tiziana Life Sciences Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.